important clinical challenge because of frequent and concurrent involvement of the arterial and venous macrocirculation.
The aim of our study was to evaluate the pathogenesis and clinical features of lower limb ulcers in SSc and to propose a classification that could be used in clinical practice.
MATERIALS AND METHODS
Charts of 60 patients with SSc seen by the Ulcer Clinic of the Rheumatology Division of University Hospital in Florence (Italy) because of lower limb cutaneous ulcers during a 5-year period (2008) (2009) (2010) (2011) (2012) (2013) were reviewed, and data were extracted from the standard forms in those charts. All patients fulfilled 2013 American College of Rheumatology/European League Against Rheumatism classification criteria 8 and were divided into limited (lcSSc) and diffuse (dcSSc) cutaneous subsets 9 . No patient had overlap syndrome with other connective tissue diseases. Our clinic adopts a clinical form to record the natural history of the ulcers, their characteristics, dimensions, recurrence, and type of medications applied. In our center, ulcers are evaluated and classified by 3 nurses specialized in wound healing and 2 rheumatologists with interest in wound healing who are involved in the patients' clinical management. In addition, rheumatologists evaluated ulcers for the presence of overt infection and whether there was a delay in the time to healing or whether complications occurred. Clinical forms were filled out by nurses and checked by rheumatologists.
All patients had videocapillaroscopy and arterial and venous lower limb color Doppler ultrasonography (US) according to the routine protocol adopted by our institution for the management of lower limb lesions in SSc.
In addition, the results of pulmonary function tests, high-resolution computed tomography lung scans, echocardiography, and renal echo Doppler performed on a regular basis within routine management of patients with SSc in our institution were recorded. Relevant clinical data were also collected from patients' history and other case-specific examinations (Appendix 1).
Involvement of arterial macrocirculation was assessed by arterial color Doppler US. Hemodynamically important arterial stenosis was diagnosed if stenosis was between 50-99%, as described 10 (Appendix 1) 10, 11, 12, 13 . Patients with hemodynamically significant peripheral arterial disease on arterial color Doppler US, with a distribution consistent with the ulcer site, underwent contrast angiography (arteriography), for which a digital subtraction angiography technique was used. The modified Brewster classification was used to classify macrovascular arterial disease detected by angiography 14 (Appendix 1). Venous insufficiency was evaluated by venous duplex imaging combining B-mode imaging of the deep and superficial veins with pulsed Doppler flow assessment, as described 12, 13 (Appendix 1). Lymphedema was suspected at clinical examination, supported by suggestive US findings when lymphatic lakes and ectasic lymphatic vessels were observed 15 .
At the time of presentation, lower limb lesions were defined as follows: (1) hyperkeratosis -hypertrophy of the stratum corneum of the skin, located in areas subject to increased friction, mainly represented by calluses and corns ( Figure 1a) ; (2) ulcer -loss of tissue involving, in different degrees, the epidermis, dermis, subcutaneous tissue, and sometimes bone; (3) calcinosis -deposits of calcium phosphate in soft tissues, visible to the naked eye and/or confirmed by radiograph; (4) gangrene -defined as necrosis of soft tissues caused by a total lack of blood supply. Dry gangrene presents macroscopically as shrunken and black tissue (Figure 1d ). Wet gangrene presents as a moist and infected tissue.
Ulcers were classified into subsets according to their origin and main features: (1) ulcers associated with hyperkeratosis -loss of tissue is usually hidden below the hyperkeratotic tissue and may easily raise suspicion, because it is characterized by inflammation and edema of perilesional skin ( Figure 1b) ; (2) ulcers secondary to calcinosis -loss of tissue caused by a mechanical action of calcinosis erupting through the skin ( Figure 1c) ; and (3) pure ulcers -loss of soft tissues not occurring in association with hyperkeratosis or in association with calcinosis (Figure 2a-c) .
The following criteria, described in the literature 16, 17, 18 , have been used to define venous, arterial, and microvascular ulcers: (1) venous ulcers, occurring in the gaiter area of the leg, particularly over the medial malleolus, have an irregular, gently sloping edge and are associated with varicosities, edema, venous dermatitis and/or lipodermatosclerosis; (2) arterial ulcers (typically occurring over the toes, heels, and bony prominences of the foot; usually have well-demarcated edges, cold surrounding skin, and often a necrotic base; and are usually associated with intermittent claudication, worsening pain following leg elevation, reduced or abolished peripheral pulses); and (3) microvascular ulcers, defined as ulcers with morphological characteristics of arterial ulcers in the absence of signs of macrovascular arterial impairment (as absent or diminished peripheral pulses).
We did not assess the morphologic and clinical features of either ulcers associated with hyperkeratosis or those secondary to calcinosis, to determine whether they fit criteria for arterial, venous, or microvascular ulcers.
Statistical analysis was done with SPSS software, version 17 (Appendix 1).
RESULTS

Patients' features and macrovascular involvement.
Sixty SSc patients with lower limb lesions attended our ulcer clinic from 2008 to 2013. About 1000 patients with SSc were followed in our center over the same time period, so we can estimate that about 6% of our SSc population presented lower limb ulcers.
Clinical features of the study population are summarized in Table 1 . Involvement of arterial macrocirculation as determined by color Doppler US was observed in 17 patients (18.3%) and of venous macrocirculation as determined by color Doppler US in 18 patients (30%; Table 1 ). There were 2 patients with hemodynamically significant peripheral macrovascular arterial disease and concomitant venous insufficiency. Macrovascular involvement was more frequent in the lcSSc subset: arterial disease was present in 16/40 patients (40%) with lcSSc and 1/20 patients (5%) with dcSSc; venous involvement was present in 15/40 patients with lcSSc (37.5%) and 3/20 patients with dcSSc (15%).
Six patients with hemodynamically significant peripheral arterial disease, identified by color Doppler US in the vascular area above the ulcer site, underwent lower limb arteriography. Of those 6 patients, 2 did not have atherosclerotic risk factors and 4 did. In patients without atherosclerotic risk factors, type IV Brewster disease was observed (diseased distal vessels below the knee with normal vessels above the knee), while all 4 patients with atherosclerotic risk factors had type III Brewster disease (multilevel disease with both proximal and distal arterial lesions with severe involvement of tibial and peroneal arteries).
Lymphedema was observed in 13 patients (21.7%). Two patients had type II diabetes mellitus, both optimally controlled by oral antidiabetics, and none of them presented diabetic neuropathy. Both presented hemodynamically significant peripheral arterial disease. Cutaneous lesions. A total of 554 lesions were observed in 60 patients. Eighteen patients (30%) presented only hyperkeratoses and never developed ulcers, 41 patients (68.3%) had at least 1 ulcer, and 3 (5%) had gangrene. Among patients with ulcers, 37/41 (90.2%) had pure ulcers, 6/41 (14.6%) had ulcers associated with hyperkeratosis, and 9/41 (21.9%) had ulcers secondary to calcinosis.
Because all patients with SSc present disease-related microangiopathy, we presumed that ulcers not secondary to hyperkeratoses or to calcinosis might present pure microvascular origin related to SSc; arterial macrovascular origin related to significant arterial macrovascular stenosis, overlapping microvascular SSc-related etiology; venous macrovascular origin, overlapping SSc-related microangiopathy; or mixed macrovascular arterial-venous origin overlapping SSc-related microangiopathy.
Classification and distribution of lower limb cutaneous lesions are shown in Table 2 .
All pure ulcers in patients with hemodynamically signifi - cant macrovascular arterial disease met morphological criteria for arterial ulcers, described above (Figure 2a) .
Only 17 out of 52 lesions (32.7%) in patients with venous insufficiency and without macrovascular arterial involvement on color Doppler US met the morphological features of venous ulcers described above. Out of 52 pure ulcers (42.3%), 22 were located on the toes, had morphological features of arterial ulcers, but were not associated with signs of macrovascular arterial impairment (as diminished pulses) and thus were likely related to SSc microangiopathy.
Two patients with concomitant venous insufficiency and hemodynamically significant arterial macrovascular disease presented a total of 16 pure ulcers, but only 1 of them met the criteria for venous ulcers (located in the medial malleolar area, site of venous dermatitis), while others were more likely microvascular/arterial lesions (Figure 2b ). Seventeen out of 37 patients with pure ulcers (45.9%) presented neither venous insufficiency nor hemodynamically significant macrovascular arterial disease assessed by color Doppler US. Hence, in these patients, pure ulcers were most likely due to SSc-related microvascular involvement only (pure microvascular ulcers).
There was a total of 76 pure ulcers in these patients: 23 (30.3%) were proximal (above ankle, including ankle) and 53 (69.7%) were distal (below ankle). Proximal lesions were observed more frequently in the lateral malleolar region When we compared patients with pure microvascular ulcers to patients with pure ulcers related to macrovascular involvement, patients with macrovascular involvement were significantly older (78.2 ± 10.6 vs 60.2 ± 17.2 yrs, respectively, p = 0.016), had more frequently lcSSc (83.2% vs 42.1%, respectively, p = 0.007), had significantly longer duration of Raynaud phenomenon (29.5 ± 13.4 vs 18.1 ± 12.7 yrs, respectively, p = 0.018), and had more frequently arterial hypertension (68.4% vs 27.8%, respectively, p = 0.044).
When we considered all patients, those with and without ulcers, and excluded patients with pure ulcers of macrovascular origin, risk factors for development of pure ulcers due to isolated microvascular involvement were represented by: dcSSc (OR 4.19, 95% CI 1.10-15.90; p = 0.035); history of lower limb ulcers (OR 30.86, 95% CI 3.34-283.82; p < 0.001); presence of ulcers in the other parts of the body excluding finger digital ulcer (DU), such as elbows, forearms, and ears (OR 4.61, 95% CI 1.01-21.07; p = 0.049); and systemic steroid treatment at the time of ulcer occurrence (OR 4.80, 95% CI 1.03-22.29; p = 0.045), in univariate analysis. Upper limb DU alone did not represent a significant risk factor for development of pure microvascular ulcers in the lower limbs. The history of lower limb ulcers remained the only statistically significant risk factor in the multivariate analysis (OR 26.67; 95% CI 2.75-259.28, p < 0.001).
Age, duration of Raynaud phenomenon and SSc, disease subset, capillaroscopic pattern, and other disease characteristics did not represent risk factors for development of microvascular pure ulcers.
Moreover, there was no difference in the use of vasodilators or immunosuppressants (cyclophosphamide, methotrexate, azathiophrine, and mycophenolate mofetil) between 4 The patients who had and did not have ulcers and between patients with microvascular and macrovascular ulcers. We observed dry gangrene of the fingertips in 3 patients. It was secondary to microvascular involvement in 1 patient (33.3%) and to significant macrovascular arterial disease in 2 (66.7%). Table 3 compares features of lower limb cutaneous lesions with features of upper limb DU of corresponding type. Data on the upper limbs have been extrapolated from our previous work on a different study population of patients with SSc 4 . Because digital pitting scars (DPS) in the upper limbs were defined as small-scale hyperkeratosis, we compared characteristics of ulcers derived from DPS to those of ulcers associated with hyperkeratosis in the lower limbs. Both in the upper and in the lower limbs, pure ulcers were defined as ulcers not occurring in association with DPS or with calcinosis.
DISCUSSION
Our work clearly demonstrates that lower limb ulcers are a significant burden for patients with SSc. For this reason, we have provided real-life data in an effort to assess their pathogenesis and to propose a classification useful for both clinical practice and clinical trials, as previously done for DU 4 .
The results of our study show that heterogeneous cutaneous lower limb lesions may be observed in SSc. Estimated prevalence of lower limb lesions in SSc in our study was around 6% over the observational period, lower than the prevalence of finger DU in SSc 19 . However, our data demonstrate that although lower limb lesions seem to be less frequent, they are much more difficult to manage than superior limb DU. Comparison with upper limb DU described in our previous study 4 indicates that lower limb lesions take longer to heal and have higher rates of infection and amputation than superior limb DU of corresponding type. We did not analyze different types of upper limb DU in this study population.
We classified lower limb lesions into 4 types (hyperkeratoses, ulcers, calcinosis, and gangrene). Subsequently, ulcers have been classified as those secondary to hyperkeratosis, secondary to calcinosis, and pure ulcers (i.e., ulcers neither secondary to calcinosis nor associated with hyperkeratosis).
Results of our study show that in SSc patients with lower limb ulcers, concomitant macrovascular arterial and/or venous disease may overlap with SSc-related microangiopathy in a substantial proportion of patients. This has to be taken into account when these lesions are managed.
We observed hemodynamically significant macrovascular arterial involvement, confirmed by arteriography, in 10% of patients, represented by type III and type IV (Brewster modified classification). In agreement with Dick, et al 14 , we observed type IV disease in SSc patients without traditional risk factors, suggesting primary macrovascular arterial involvement in SSc, not correlated to atherosclerosis, as described 5, 20, 21 .
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Personal non-commercial use only. The Journal of Rheumatology Copyright © 2016. All rights reserved. In our cohort, venous pathology was detected in 30% of patients. It is interesting to note that 40% of ulcers in patients with venous insufficiency had features of microvascular lesions, and thus were most likely due to SSc-related microangiopathy.
Progressive loss of lymphatic vessels in skin of patients with SSc has been described 22 . However, there are no data on prevalence of lymphedema in patients with SSc. We observed lymphedema in 20% of patients.
In our study, there was a substantial subpopulation of patients who presented pure ulcers but did not have macrovascular involvement (45.9%); thus we presumed that pure ulcers in these patients were due to SSc-related microangiopathy. These lesions were more frequently distal (below the ankle) and had morphological characteristics of arterial ulcers, but were not associated with absent pulses and/or intermittent claudication.
Pure microvascular ulcers were more frequent in dcSSc than in lcSSc, as reported for DU of the upper limbs in SSc 19 . However, when we considered all pure ulcers together (both microvascular and macrovascular), pure microvascular ulcers were more frequent in lcSSc than in dcSSc (63.2% and 36.8% of patients, respectively). This is because macrovascular involvement is more frequent in lcSSc that in dcSSc, as suggested by our results.
Risk factors for development of pure ulcers from isolated microvascular involvement in univariate analysis were: dcSSc, history of pure ulcers in the lower limbs, presence of ulcers in the other parts of the body excluding finger DU, and systemic steroid treatment at the time of ulcer occurrence. A history of lower limb ulcers remained the only significant risk factor in multivariate analysis. Interestingly, the upper limb DU alone did not represent risk factors for development of pure microvascular ulcers in the lower limbs.
Some ulcers observed in our study did not seem to have pure vascular pathogenesis because they were related to hyperkeratosis or were consequences of calcinosis. This is in accordance with data observed in our previous study on upper limb ulcers 4 .
The main limitations of the study are the retrospective design and the fact that not all the patients had arteriography, but only those with hemodynamically significant peripheral arterial disease on arterial color Doppler US.
Another important limitation is that we did not evaluate interobserver reproducibility of our classification, although in our clinical practice it seems to be very high.
The results of our study indicate that lower limb ulcers in SSc often have a multifactorial pathogenesis that should be taken into account when dealing with these lesions. Moreover, they may be more difficult to manage compared to DU of the upper limbs. Lower limb ulcers are a rare complication of SSc, but represent a heavy clinical burden for patients. Further studies are needed to verify the classifications we have proposed and to assess the most appropriate management of SSc patients with lower limb ulcers according to their origin.
